To the Editor:

The MMAC1/PTEN gene is localized on chromosome 10q23.3 and encodes a putative tumor suppressor with structural homologies to known phosphatases and cytoskeletal proteins.1,2 Functional studies have shown that MMAC1/PTEN is a dual-specificity protein phosphatase that dephosphorylates tyrosine, serine, and threonine.3,4 Germline mutations of MMAC1/PTEN have been implicated as the predisposing factor in Cowden disease,5 and loss of function mutations have been found in a variety of sporadic solid cancers.1,2,6 Previous observations of 10q abnormalities in lymphoproliferative diseases7,8 suggest that MMAC1/PTEN may possibly be involved in lymphomagenesis.

We systematically studied 14 malignant and 4 benign lymphoid cell lines for deletions and mutations in all exons of the MMAC1/PTEN gene by combining polymerase chain reaction (PCR), denaturing gradient gel electrophoresis (DGGE) and direct sequence analysis.9Overall, alterations of MMAC1/PTEN were shown in 2 of the malignant cell lines and in none of the benign cell lines. The T-cell acute lymphoblastic leukemia cell line CCRF-CEM harbored homozygous deletion of a genomic region including exons 2 through 5. In the myeloma cell line HS-Sultan, we identified a C → T transition at the first base of codon 17, resulting in the substitution of glutamine with a premature termination signal. This cell line also showed loss of the wild-type allele.

We next examined all exons of the MMAC1/PTEN gene by PCR/DGGE analysis in 170 primary lymphoid malignancies (Fig 1). This approach led to the detection of point mutations in 2 (5%) of 39 diffuse large B-cell lymphomas. One of the samples harbored a G → C transversion at the third base of codon 342, which is predicted to cause the substitution of lysine with asparagine. This mutation affects the last base of exon 8, which is considered to be part of the donor-splice site consensus sequence required for correct splicing of pre-mRNA.10 Several examples of mutations at position −1 of donor-splice sites that cause skipping of the preceding exon have been reported.11Whether the MMAC1/PTEN Lys342Asn mutation has functional consequences with respect to splicing remains to be investigated. Analysis of normal tissue from the patient showed only the normal sequence, documenting that the mutation occurred somatically. The second sample harbored a G → A transition at the second base of codon 10, causing substitution of serine with asparagine. This residue is conserved in auxilin and the hypothetical yeast PTPase, YNL128W.1 Semiquantitative DGGE analysis9showed unequal distribution of mutant and wild-type sequences, suggesting that the mutation was present in only a subpopulation of cells. None of the mutations we identified have been reported to occur in normal tissues.12 

Fig. 1.

Detection and identification of MMAC1/PTENmutations in primary lymphomas. (A) PCR/DGGE analysis ofMMAC1/PTEN exon 1 in 10 tumor samples. (B) Direct sequence analysis of the sample displaying an aberrant band pattern in (A). The partial sequence ladder shows a G → A transition, resulting in the substitution of Ser10 with Asn10.

Fig. 1.

Detection and identification of MMAC1/PTENmutations in primary lymphomas. (A) PCR/DGGE analysis ofMMAC1/PTEN exon 1 in 10 tumor samples. (B) Direct sequence analysis of the sample displaying an aberrant band pattern in (A). The partial sequence ladder shows a G → A transition, resulting in the substitution of Ser10 with Asn10.

Although MMAC1/PTEN alterations were found in only a minority of lymphoma cell lines and tumor samples, our results, together with the recent demonstration of mutations in leukemia cell lines,6 indicate that MMAC1/PTEN may be a target in the pathogenesis or progression of some forms of hematological malignancy.

ACKNOWLEDGMENT

We are grateful to Dr H.E. Johnsen who generously provided cell lines, and to V. Ahrenkiel and L. Jensen for expert technical assistance. Supported by grants from the Danish Cancer Society, Kong Christian X's Foundation, the Hasselbalch Foundation, and Søeborg Ohlsens Foundation.

REFERENCES

REFERENCES
1
Steck
PA
Pershouse
MA
Jasser
SA
Yung
WK
Lin
H
Ligon
AH
Langford
LA
Baumgard
ML
Hattier
T
Davis
T
Frye
C
Hu
R
Swedlund
B
Teng
DH
Tavtigian
SV
Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers.
Nat Genet
15
1997
356
2
Li
J
Yen
C
Liaw
D
Podsypanina
K
Bose
S
Wang
SI
Puc
J
Miliaresis
C
Rodgers
L
McCombie
R
Bigner
SH
Giovanella
BC
Ittmann
M
Tycko
B
Hibshoosh
H
Wigler
MH
Parsons
R
PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer.
Science
275
1997
1943
3
Li
D-M
Sun
H
TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor β.
Cancer Res
57
1997
2124
4
Myers
MP
Stolarov
JP
Eng
C
Li
J
Wang
SI
Wigler
MH
Parsons
R
Tonks
NK
P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase.
Proc Natl Acad Sci USA
94
1997
9052
5
Liaw
D
Marsh
DJ
Li
J
Dahia
PL
Wang
SI
Zheng
Z
Bose
S
Call
KM
Tsou
HC
Peacocke
M
Eng
C
Parsons
R
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
Nat Genet
16
1997
64
6
Teng
DH
Hu
R
Lin
H
Davis
T
Iliev
D
Frye
C
Swedlund
B
Hansen
KL
Vinson
VL
Gumpper
KL
Ellis
L
El-Naggar
A
Frazier
M
Jasser
S
Langford
LA
Lee
J
Mills
GB
Pershouse
MA
Pollack
RE
Tornos
C
Troncoso
P
Yung
WK
Fujii
G
Berson
A
Steck
PA
MMAC1/PTEN mutations in primary tumor specimens and tumor cell lines.
Cancer Res
57
1997
5221
7
Speaks
SL
Sanger
WG
Masih
AS
Harrington
DS
Hess
M
Armitage
JO
Recurrent abnormalities of chromosome bands 10q23-25 in non- Hodgkin's lymphoma.
Genes Chromosomes Cancer
5
1992
239
8
Takeuchi
S
Bartram
CR
Wada
M
Reiter
A
Hatta
Y
Seriu
T
Lee
E
Miller
CW
Miyoshi
I
Koeffler
HP
Allelotype analysis of childhood acute lymphoblastic leukemia.
Cancer Res
55
1995
5377
9
Guldberg
P
thor Straten
P
Birck
A
Ahrenkiel
V
Kirkin
AF
Zeuthen
J
Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma.
Cancer Res
57
1997
3660
10
Padgett
RA
Grabowski
PJ
Konarska
MM
Seiler
S
Sharp
PA
Splicing of messenger RNA precursors.
Annu Rev Biochem
55
1986
1119
11
Krawczak
M
Reiss
J
Cooper
DN
The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences.
Hum Genet
90
1992
41
12
Tsou
HC
Teng
DH
Ping
XL
Brancolini
V
Davis
T
Hu
R
Xie
XX
Gruener
AC
Schrager
CA
Christiano
AM
Eng
C
Steck
P
Ott
J
Tavtigian
SV
Peacocke
M
The role of MMAC1 mutations in early-onset breast cancer: Causative in association with Cowden syndrome and excluded in BRCA1-negative cases.
Am J Hum Genet
61
1997
1036